SEC Tracker
Get the app

Aligos Therapeutics ALGS

In connection with the previously disclosed resignation of Leonid Beigelman

Form
8-K
Filed
Period
Importance
Major
Document
8-K
  • Reports an executive or board change (5.02)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Aligos Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2836 and related industry codes: the same peer list as the financial tables.

  1. CEL-SCI CVM public float $19M, Mar 31, 2025, over 18 months old
  2. Relmada Therapeutics RLMD public float $19M, Jun 30, 2025
  3. Fibrogen FGEN public float $21M, Jun 30, 2025
  4. Armata Pharmaceuticals ARMP public float $21M, Jun 30, 2025
  5. Imunon IMNN public float $21M, Jun 30, 2025